Published in

MDPI, Nutrients, 10(14), p. 2119, 2022

DOI: 10.3390/nu14102119

Links

Tools

Export citation

Search in Google Scholar

Reply to Skokou, M. Comment on “Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158”

Journal article published in 2022 by Johanna Louise Keeler ORCID, Janet Treasure, Mario F. Juruena ORCID, Carol Kan, Hubertus Himmerich ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

In response to our narrative review, which suggested the use of the glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a potential treatment for anorexia nervosa (AN) [...]